X

Vista Pharmaceuticals Ltd. Stock Analysis

Small Cap
Evaluated by 222 users | BSE: 524711 | NSE: |
Pharmaceuticals & Drugs
Vista Pharmaceuticals Limited was incorporated on January 25,1991 under the Companies Act of 1956 with the Registrar of Companies Andhra Pradesh & has obtained Certificate of Commencement of Business on February 7, 1991. Vista Pharmaceuticals was incorporated by Dr. Dhananjaya Alli &...

Analysis of Financial Track Record

Data adjusted to bonus, split, extra-ordinary income, rights issue and change in financial year end
Financial track record gives insight into the company's performance on key parameters over the past ten years. MoneyWorks4me’s proprietary colour codes make it easy for retail investors to gauge the company’s past performance.
Value Creation
 Mar'10Mar'11Mar'12Mar'13Mar'14Mar'15Mar'16Mar'17Mar'18Mar'19
Return on Capital Employed -11.83%-2.72%-17.46%1%5.29%14.46%8.37%7.91%8.84%2.64%
Growth Parameters
Growth Parameters Colour Code Guide
Net Sales (Rs. Cr.) 0.85.73.67.58.313.815.424.228.931.1
Y-o-Y Gr. Rt.-608.8%-36.2%106.4%11.1%65.7%11.9%57.2%19.6%7.4%
Adjusted EPS (Rs.) -0.9-0.19-1.110.050.310.570.350.470.70
Y-o-Y Gr. Rt.-NANANA520%83.9%-38.6%34.3%48.9%-100%
Book Value per Share (Rs.) 76.815.75.756.064.174.486.259.0210.97
Adjusted Net Profit -1.4-0.3-1.70.10.51.40.91.320
Net Op. Cash Flow (Rs. Cr.) 0.90.50.30.2-0.1-3.5-2.52.6-4.63.3
Debt to Cash Flow from Ops 00000-1.14-3.164.41-2.413.39
Standalone financials take only the parent company into account while consolidated financials take into account financials of the parent company as well as of all its subsidiaries. In most companies consolidated financials should be used for analysis.
Vista Pharmaceuticals Ltd. should be analysed on a Standalone basis
CAGR
CAGR Colour Code Guide
  9 yrs 5 yrs 3 yrs 1 yr
Net Sales 50.2%30.2%26.4%7.4%
Adjusted EPS NA-100%-100%-100%
Book Value per Share 5.112.634.821.6
Share Price -0% -11.2% -42.3% -9.2%
Key Financial Parameter
Performance Ratio Colour Code Guide
 Mar'10Mar'11Mar'12Mar'13Mar'14Mar'15Mar'16Mar'17Mar'18Mar'19
Return on Equity (%) -11.85-2.78-17.540.935.2714.588.978.370.04
Operating Profit Margin (%) -133.084.07-24.8310.9114.7120.2517.7412.6418.473.98
Net Profit Margin (%) -168.48-5.15-45.911.085.6210.35.635.167.010.04
Debt to Equity 000000.390.70.680.420.34
Working Capital Days 294761648390189332270290287
Cash Conversion Cycle 71-85-99-82-119-17955259153
Entity Percentage Holding
Promoters 31.48%
Institutions 0.28%
Non-Institutions 68.24%
Pledged *0.000.000.000.000.000.000.000.000.000.00
* Pledged shares as % of Promoter's holding (%)
Data is not available for this company.

The 5-year analysis of Vista Pharmaceuticals Ltd.'s performance infers:

Vista Pharmaceuticals Ltd. earnings have declined by -100%, whereas share price has depreciated -11.2% CAGR over the past five years, indicating the company's share price is likely overvalued. However, for specific investment actions please connect with your investment advisor.

We analysed the performance of Vista Pharmaceuticals Ltd. share prices over the last 10 years. Here is what we found out:

Vista Pharmaceuticals Ltd. share price has depreciated -4.5% annually over the past ten years.

Vista Pharmaceuticals Limited was incorporated on January 25,1991 under the Companies Act of 1956 with the Registrar of Companies Andhra Pradesh & has obtained Certificate of Commencement of Business on February 7, 1991. Vista Pharmaceuticals was incorporated by Dr. Dhananjaya Alli & his associates. The capital was subscribed by Vista Pharmaceuticals Inc., an Overseas Corporate Body promoted by them as a per the laws of State of New Jersy, United States of America.

The Company was

Vista Pharmaceuticals Limited was incorporated on January 25,1991 under the Companies Act of 1956 with the Registrar of Companies Andhra Pradesh & has obtained Certificate of Commencement of Business on February 7, 1991. Vista Pharmaceuticals was incorporated by Dr. Dhananjaya Alli & his associates. The capital was subscribed by Vista Pharmaceuticals Inc., an Overseas Corporate Body promoted by them as a per the laws of State of New Jersy, United States of America.

The Company was in process of setting up a 100% EOU for manufcacture of drug formulations with an installed capacity of 400 million tablets & 200 million capsules per annum.

Vista, the largest division of Torrent Pharmaceuticals Ltd, offers a range of products mainly in the therapeutic areas of gastrointestinal, pain management and anti-infective, catering to common ailments. This division is a primary contributor to the domestic sales of Torrent Pharmaceuticals Ltd.

Puchho Befikar
SEBI Registered: Investment Adviser - INA000013323
Research Analyst - INH000000719

Callback